Genenta Science S.p.A (GNTA) Enterprise Value (2020 - 2025)
Genenta Science S.p.A (GNTA) posted Enterprise Value of -$59.1 million for Q4 2025, down 195.5% sequentially from -$20.0 million in Q2 2025, and down 166.69% YoY from $88.6 million in Q4 2024.
Genenta Science S.p.A (GNTA) Enterprise Value (2020 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Enterprise Value for 6 years, with the latest figure at -$59.1 million in Q4 2025.
- Quarterly Enterprise Value fell 166.69% year-over-year to -$59.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$59.1 million (down 166.69% YoY) and the FY2025 annual result came in at -$59.1 million, down 166.69% from the prior year.
- Enterprise Value eased to -$59.1 million in Q4 2025 per GNTA's latest filing, from -$20.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$10.9 million in Q2 2023 and troughed at -$59.1 million in Q4 2025.
- A 5-year average of -$30.0 million and a median of -$30.4 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 70.44% in 2023, then plunged 166.69% in 2025.
- Over 5 years, Enterprise Value stood at -$42.6 million in 2021, then increased by 28.65% to -$30.4 million in 2022, then retreated by 19.85% to -$36.4 million in 2023, then surged by 39.17% to -$22.2 million in 2024, then slumped by 166.69% to -$59.1 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$59.1 million, -$20.0 million, and -$22.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.12 Bn |
| 10 | Genenta Science S.p.A | 24.54 Mn | -34.56 Mn | - | -59.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -59.10 Mn |
| Jun 30, 2025 | -20.00 Mn |
| Dec 31, 2024 | -22.16 Mn |
| Jun 30, 2024 | -11.56 Mn |
| Dec 31, 2023 | -36.43 Mn |
| Jun 30, 2023 | -10.94 Mn |
| Dec 31, 2022 | -30.40 Mn |
| Jun 30, 2022 | -37.00 Mn |
| Dec 31, 2021 | -42.60 Mn |
| Dec 31, 2020 | -18.44 Mn |